Benaroya Research Institute's third annual immunology symposium, New Horizons in Immunity and Disease, will take place on Tuesday, May 5, 2026. Due to strong interest and enthusiastic support from the immunology community, we’re relocating this year’s event to Bell Harbor International Conference Center in Seattle, a larger venue that will better accommodate our growing audience.
We’re excited to once again bring together leading voices from the local and national immunology research community for a day of collaboration, discovery, discussion and connection. Building on two years of full houses, dynamic presentations, and meaningful dialogue, this year’s symposium is set to continue that momentum.
More details, including program highlights and event speakers, will be shared soon.
Please contact BRI's marketing and communications team via email with any questions.
BRI Immunology Symposium Speakers
The program features two standout keynote speakers, Jay Shendure, MD, PhD, and Phil Greenberg, MD, alongside a strong lineup of nationally and locally recognized researchers from institutions including BRI, the University of Washington, and the Allen Institute for Immunology. Additional speakers and the full agenda will be announced in the coming months. Registration is now open.
BRI Thanks Our Generous Sponsors
Thank you to our partners, supporters and collaborators. Please stop by the booth area at the symposium to connect.
News
New Study Links Noncoding DNA Genetic Variants to Root Causes of Rheumatoid Arthritis
Read More
Regulatory T Cell-Boosting Therapy Impacts Flu Responses — For Better or Worse — Depending on Timing
Read More
New Research Reveals Rheumatoid Arthritis Begins Years Before Symptoms
Read More ➡
Featured Publications
Associations between dietary patterns and diabetes in patients with acute pancreatitis: a cross-sectional analysis from the DREAM study
J Nutr
Filgotinib treatment modulates frequency and gene expression of circulating immune cell subsets in ulcerative colitis
J Crohns Colitis
Differential effects of subcutaneous and sublingual immunotherapy on timothy grass-specific TH2 CD4+ T-cell subsets
J Allergy Clin Immunol
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Nat Microbiol
Immunology of Sepsis
Clin Chest Med
